Transplantation, Autologous
"Transplantation, Autologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of an individual's own tissue from one site to another site.
Concept/Terms
Transplantation, Autologous- Transplantation, Autologous
- Autologous Transplantations
- Transplantations, Autologous
- Autotransplantion
- Autotransplantions
- Autografting
- Autograftings
- Autologous Transplantation
Below are MeSH descriptors whose meaning is more general than "Transplantation, Autologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Autologous".
This graph shows the total number of publications written about "Transplantation, Autologous" by people in Harvard Catalyst Profiles by year, and whether "Transplantation, Autologous" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 20 | 20 |
| 1994 | 0 | 16 | 16 |
| 1995 | 0 | 13 | 13 |
| 1996 | 1 | 22 | 23 |
| 1997 | 0 | 24 | 24 |
| 1998 | 0 | 35 | 35 |
| 1999 | 3 | 26 | 29 |
| 2000 | 4 | 23 | 27 |
| 2001 | 0 | 29 | 29 |
| 2002 | 0 | 18 | 18 |
| 2003 | 1 | 25 | 26 |
| 2004 | 2 | 35 | 37 |
| 2005 | 0 | 23 | 23 |
| 2006 | 2 | 29 | 31 |
| 2007 | 3 | 18 | 21 |
| 2008 | 2 | 14 | 16 |
| 2009 | 2 | 28 | 30 |
| 2010 | 3 | 27 | 30 |
| 2011 | 1 | 34 | 35 |
| 2012 | 1 | 32 | 33 |
| 2013 | 0 | 33 | 33 |
| 2014 | 2 | 29 | 31 |
| 2015 | 1 | 38 | 39 |
| 2016 | 1 | 45 | 46 |
| 2017 | 4 | 40 | 44 |
| 2018 | 4 | 50 | 54 |
| 2019 | 3 | 41 | 44 |
| 2020 | 1 | 45 | 46 |
| 2021 | 0 | 41 | 41 |
| 2022 | 0 | 41 | 41 |
Below are the most recent publications written about "Transplantation, Autologous" by people in Profiles.
-
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience. Transplant Cell Ther. 2023 Apr; 29(4):260.e1-260.e6.
-
The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease. Oncology (Williston Park). 2022 12 20; 36(12):718-727.
-
Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL. Blood Adv. 2022 12 13; 6(23):5969-5979.
-
Sequencing therapy in relapsed DLBCL. Hematology Am Soc Hematol Educ Program. 2022 12 09; 2022(1):146-154.
-
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials. Transplant Cell Ther. 2023 Mar; 29(3):174.e1-174.e10.
-
Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment. Curr Oncol. 2022 11 21; 29(11):8975-9005.
-
Interprofessional Team-based Care of the Hematopoietic Cell Transplantation Patient With Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome. J Pediatr Hematol Oncol. 2023 01 01; 45(1):12-17.
-
Two Cases of Delayed Flexor Tendon Rupture Decades After Reconstruction. Hand (N Y). 2023 03; 18(2):NP11-NP15.
-
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study. Br J Haematol. 2022 11; 199(3):355-365.
-
Optimizing the Use of Autografts, Allografts, and Alloplastic Materials in Rhinoplasty. Plast Reconstr Surg. 2022 09 01; 150(3):675e-683e.